Inhibition of actin polymerization decreases osteogeneic differentiation of mesenchymal stem cells through p38 MAPK

Himangshu Sonowal1, Atul Kumar, Jina Bhattacharyya

  • 1Stem Cell and Cancer Biology Group, Indian Institute of Technology Guwahati, Guwahati, Assam, India. bithiahgj@iitg.ernet.in.

Abstract

Insights

Actin modification is crucial for mesenchymal stem cell (MSC) differentiation into bone or fat cells. Controlling the actin cytoskeleton may regulate MSC differentiation for tissue repair.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Regenerative Medicine

Background:

  • Mesenchymal Stem Cells (MSCs) possess therapeutic potential due to their proliferation and differentiation capabilities.
  • MSC differentiation is influenced by intrinsic and extrinsic factors, with the actin cytoskeleton playing a key role.
  • Understanding the molecular mechanisms regulating MSC differentiation into osteocytes or adipocytes is crucial.

Purpose of the Study:

  • To investigate the initial molecular mechanisms and pathways governing MSC differentiation into osteocytes and adipocytes.
  • To elucidate the role of actin cytoskeleton modifications in MSC differentiation.

Main Methods:

  • Studying actin polymerization and its impact on MSC differentiation.
  • Analyzing the phosphorylation of ERK1/2 and p38 MAPK during osteogenic differentiation.
  • Investigating the effect of actin polymerization inhibition on differentiation markers like CD49E expression.

Main Results:

  • Actin modification is essential and differentially regulated during adipogenesis and osteogenesis.
  • Disrupting actin polymerization initially hinders osteogenic differentiation.
  • Osteogenic differentiation involves increased ERK1/2 and p38 MAPK phosphorylation, with p38 MAPK being downregulated upon actin polymerization inhibition, accompanied by decreased CD49E expression.

Conclusions:

  • Actin modification is a prerequisite for MSC differentiation into osteocytes and adipocytes.
  • Osteogenic differentiation is regulated via p38 MAPK phosphorylation.
  • Modulating the MSC cytoskeleton offers potential for controlling differentiation in tissue repair and regeneration.